Catheter Precision (VTAK) Consolidated Net Income (2017 - 2026)

Catheter Precision (VTAK) has reported Consolidated Net Income for 10 consecutive years, with -$3.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Consolidated Net Income rose 38.87% year-over-year to -$3.3 million in Q2 2026; TTM through Jun 2026 was -$10.7 million, a 44.03% increase from a year earlier, with the FY2025 full-year figure at -$15.4 million, up 7.41% from the prior year.
• Consolidated Net Income was -$3.3 million for Q2 2026 at Catheter Precision, down from -$1.7 million in the prior quarter.
• Over five years, Consolidated Net Income peaked at -$669000.0 in Q4 2023 and troughed at -$66.4 million in Q1 2023.
• A 5-year average of -$7.5 million and a median of -$4.1 million in 2024 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income slumped 1108.37% in 2023 and surged 95.97% in 2024, its largest moves.
• Over 5 years, Consolidated Net Income stood at -$8.2 million in 2022, then jumped by 91.8% to -$669000.0 in 2023, then sank by 741.26% to -$5.6 million in 2024, then surged by 36.71% to -$3.6 million in 2025, then gained by 7.19% to -$3.3 million in 2026.
• The last three Consolidated Net Income figures came in at -$3.3 million (Q2 2026), -$1.7 million (Q1 2026), and -$3.6 million (Q4 2025), per Business Quant data.